Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · IEX Real-Time Price · USD
31.01
-0.22 (-0.70%)
May 2, 2024, 4:00 PM EDT - Market closed
Sanara MedTech Revenue
In the year 2023, Sanara MedTech had annual revenue of $64.99M with 41.77% growth. Revenue in the quarter ending December 31, 2023 was $17.69M with 15.50% year-over-year growth.
Revenue (ttm)
$64.99M
Revenue Growth
+41.77%
P/S Ratio
4.11
Revenue / Employee
$607,382
Employees
107
Market Cap
267.39M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
Dec 31, 2020 | 15.59M | 3.82M | 32.47% |
Dec 31, 2019 | 11.77M | 5.93M | 101.56% |
Dec 31, 2018 | 5.84M | -466.90K | -7.41% |
Dec 31, 2017 | 6.30M | 796.89K | 14.47% |
Dec 31, 2016 | 5.51M | 2.14M | 63.33% |
Dec 31, 2015 | 3.37M | 739.55K | 28.09% |
Dec 31, 2014 | 2.63M | 906.25K | 52.49% |
Dec 31, 2013 | 1.73M | 552.85K | 47.11% |
Dec 31, 2012 | 1.17M | -1.04M | -46.89% |
Dec 31, 2011 | 2.21M | 1.30M | 142.71% |
Dec 31, 2010 | 910.42K | 622.40K | 216.10% |
Dec 31, 2009 | 288.02K | -2.16K | -0.75% |
Dec 31, 2008 | 290.18K | -340.32K | -53.98% |
Dec 31, 2007 | 630.51K | 440.75K | 232.27% |
Dec 31, 2006 | 189.76K | -21.41K | -10.14% |
Dec 31, 2005 | 211.17K | 37.08K | 21.30% |
Dec 31, 2004 | 174.09K | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 125.00K | 104.04K | 496.40% |
Dec 31, 2001 | 20.96K | 16.37K | 356.72% |
Dec 31, 2000 | 4.59K | -2.25M | -99.80% |
Dec 31, 1999 | 2.25M | -573.97K | -20.32% |
Dec 31, 1998 | 2.82M | -1.01M | -26.41% |
Dec 31, 1997 | 3.84M | 851.08K | 28.49% |
Dec 31, 1996 | 2.99M | 2.23M | 296.06% |
Dec 31, 1995 | 754.15K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Vanda Pharmaceuticals | 192.64M |
AxoGen | 159.01M |
Nektar Therapeutics | 90.12M |
ChromaDex | 83.57M |
Sight Sciences | 81.06M |
Nanobiotix | 40.23M |
TriSalus Life Sciences | 18.51M |
Opthea | 385.28K |
SMTI News
- 3 days ago - Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates - GlobeNewsWire
- 14 days ago - Sanara MedTech Inc. Announces $55 Million Debt Facility - GlobeNewsWire
- 27 days ago - Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer - GlobeNewsWire
- 5 weeks ago - Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 7 weeks ago - Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates - GlobeNewsWire
- 2 months ago - Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023 - GlobeNewsWire
- 4 months ago - Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides - GlobeNewsWire
- 5 months ago - Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing - GlobeNewsWire